Chronic lead treatment affects dopaminergic control of prolactin secretion in rat pituitary

Toxicology Letters

Volumn 20, Issue 3, 1984, Pages 237-241

  Govoni, S ^a   Lucchi, L ^a   Battaini, F ^a   Spano, P F ^a   Trabucchi, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

dihydroxyphenylacetic acid; dopamine; hypothalamus; Lead; pituitary; prolactin

Indexed keywords

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DOPAMINE; HYPOTHALAMUS; LEAD POISONING; PITUITARY GLAND; PROLACTIN; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE;

ANIMALIA;

EID: 0021333602     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4274(84)90154-1     Document Type: Article

References (20)

1. The interaction between lead and catecholaminergic function
2. Chronic lead treatment differentially affects dopamine synthesis in various rat brain areas
3. Regional alterations of brain biogenic amines in young rats following chronic lead exposure
4. Chronic lead exposure in immature animals: neurochemical correlates
5. Effect of chronic lead treatment on brain Dopamine synthesis and serum prolactin release in the rat
6. Lead poisoning on reproduction: effects on pituitary and serum gonadotropins in neonatal rats
7. Chronic low level lead toxicity in the rat
8. Plasma hormone levels in normal and lead treated pregnant mice
9. Reproductive ability of workmen occupationally exposed to lead
10. Stimulation of Dopamine D-2 receptors by dopaminergic ergot alkaloids: studies on the mechanism of action
11. Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary
12. 3H]-(−)-sulpiride, a selective antagonist at dopamine D-2 receptors in rat CNS
13. Psychophysiological effects of early lead exposure
14. Determination of catecholamines in rat brain parts by reverse phase ion pair liquid chromatography
15. Protein measurement with the Folin phenol reagent
16. Prolactin and Growth hormone production as influenced by catecholamines and agents that affect brain catecholamines
17. Dopamine/neuroleptic receptors in basal hypothalamus and pituitary
18. 3H-Spiroperidol labels dopamine receptors in pituitary and brain
19. Dopamine receptor sites in the anterior pituitary
20. The inhibition of cerebral high affinity receptor sites by lead and mercury compounds